Analytical, Diagnostic and Therapeutic Techniques and Equipment – Anesthesia and Analgesia

The department explores advanced anesthesia and analgesia methods, especially for orthopedic procedures. Recent work assesses the impact of ultrasound‑guided brachial plexus nerve block in patients with distal radius fracture undergoing closed reduction, aiming to improve pain control while minimizing side effects.

  • Regional anesthesia techniques for fracture management
  • Imaging‑assisted nerve block procedures
  • Safety and efficacy comparison with standard care
  • Integration of analgesic protocols into postoperative pathways

Zealand University Hospital’s surgical team collaborates with anesthesiology specialists to integrate imaging technologies into routine care.

Diseases – Digestive System Diseases

Research targets gastrointestinal malignancies, focusing on localised dMMR colon cancer. A key study evaluates the proportion of patients achieving a clinical complete response after treatment with pembrolizumab, seeking to refine non‑surgical management options.

  • Immunotherapy outcomes in mismatch repair‑deficient tumors
  • Biomarker identification for response prediction
  • Evaluation of organ‑preserving treatment strategies
  • Long‑term surveillance of complete responders

The Department of Surgery leads the effort, leveraging the hospital’s oncology expertise.

Diseases – Musculoskeletal Diseases

Clinical investigations address acute bone injuries, with emphasis on distal radius fracture care. Trials compare innovative regional anesthesia techniques to conventional analgesia during closed reduction, aiming to accelerate recovery and reduce opioid use.

  • Pain management strategies for fracture reduction
  • Functional outcome assessment after nerve block
  • Opioid‑sparing protocols in orthopedic surgery
  • Early mobilization and rehabilitation pathways

The site’s orthopedic surgeons at Zealand University Hospital coordinate patient enrollment and outcome monitoring.

Diseases – Neoplasms

Oncologic programs examine immune‑based therapies across tumor types. Studies measure clinical complete response rates and explore predictive biomarkers to personalize treatment strategies.

  • Immune checkpoint inhibitor efficacy in solid tumors
  • Molecular profiling for therapy selection
  • Assessment of response durability and quality of life
  • Collaborative multidisciplinary cancer care pathways

Multidisciplinary teams at the hospital integrate surgery, pathology, and medical oncology to advance cancer care.